These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12911847)

  • 1. Isoprenoid metabolism and the pleiotropic effects of statins.
    Laufs U; Liao JK
    Curr Atheroscler Rep; 2003 Sep; 5(5):372-8. PubMed ID: 12911847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoprenoids as mediators of the biological effects of statins.
    Liao JK
    J Clin Invest; 2002 Aug; 110(3):285-8. PubMed ID: 12163444
    [No Abstract]   [Full Text] [Related]  

  • 3. Pleiotropic Effects of Statins on the Cardiovascular System.
    Oesterle A; Laufs U; Liao JK
    Circ Res; 2017 Jan; 120(1):229-243. PubMed ID: 28057795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins and ischemic stroke.
    Liao JK
    Atheroscler Suppl; 2002 May; 3(1):21-5. PubMed ID: 12044582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of mesangial cell proliferation by the mevalonate pathway.
    Massy ZA; Guijarro C; O'Donnell MP; Kasiske BL; Keane WF
    Contrib Nephrol; 1997; 120():191-6. PubMed ID: 9257061
    [No Abstract]   [Full Text] [Related]  

  • 6. Mevalonate Cascade and its Regulation in Cholesterol Metabolism in Different Tissues in Health and Disease.
    Hashemi M; Hoshyar R; Ande SR; Chen QM; Solomon C; Zuse A; Naderi M
    Curr Mol Pharmacol; 2017; 10(1):13-26. PubMed ID: 26758949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins and plaque stability.
    Gomberg-Maitland M; Fuster V; Fayad ZA; Badimon JJ; Corti R
    J Cardiovasc Risk; 2003 Jun; 10(3):161-7. PubMed ID: 12775948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Mevalonate Pathway in Cancer.
    Juarez D; Fruman DA
    Trends Cancer; 2021 Jun; 7(6):525-540. PubMed ID: 33358111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lovastatin and mevastatin reduce basal and cytokine-stimulated production of prostaglandins from rat microglial cells in vitro: evidence for a mechanism unrelated to the inhibition of hydroxy-methyl-glutaryl CoA reductase.
    Tringali G; Vairano M; Dello Russo C; Preziosi P; Navarra P
    Neurosci Lett; 2004 Jan; 354(2):107-10. PubMed ID: 14698450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of statins in inflammation and atherosclerosis.
    Yoshida M
    J Atheroscler Thromb; 2003; 10(3):140-4. PubMed ID: 14564082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
    Danesh FR; Kanwar YS
    FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of mevalonate pathway in osteogenic cells].
    Ishimi Y
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():779-82. PubMed ID: 15035226
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperlipidaemia and cardiovascular disease: nonlipid-lowering effects of omega-3 fatty acids, statins and fibrates.
    Dominiczak M
    Curr Opin Lipidol; 2009 Feb; 20(1):79-81. PubMed ID: 19106712
    [No Abstract]   [Full Text] [Related]  

  • 14. Geranylgeranyl-pyrophosphate, an isoprenoid of mevalonate cascade, is a critical compound for rat primary cultured cortical neurons to protect the cell death induced by 3-hydroxy-3-methylglutaryl-CoA reductase inhibition.
    Tanaka T; Tatsuno I; Uchida D; Moroo I; Morio H; Nakamura S; Noguchi Y; Yasuda T; Kitagawa M; Saito Y; Hirai A
    J Neurosci; 2000 Apr; 20(8):2852-9. PubMed ID: 10751437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pitavastatin on transactivation of human serum paraoxonase 1 gene.
    Ota K; Suehiro T; Arii K; Ikeda Y; Kumon Y; Osaki F; Hashimoto K
    Metabolism; 2005 Feb; 54(2):142-50. PubMed ID: 15690306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleiotropic effects of statins.
    Liao JK; Laufs U
    Annu Rev Pharmacol Toxicol; 2005; 45():89-118. PubMed ID: 15822172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome.
    Frenkel J; Rijkers GT; Mandey SH; Buurman SW; Houten SM; Wanders RJ; Waterham HR; Kuis W
    Arthritis Rheum; 2002 Oct; 46(10):2794-803. PubMed ID: 12384940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitavastatin decreases the expression of endothelial lipase both in vitro and in vivo.
    Kojima Y; Ishida T; Sun L; Yasuda T; Toh R; Rikitake Y; Fukuda A; Kume N; Koshiyama H; Taniguchi A; Hirata K
    Cardiovasc Res; 2010 Jul; 87(2):385-93. PubMed ID: 20045866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Near normal levels of isoprenoid lipids in severe mevalonic aciduria.
    Keller RK; Simonet WS
    Biochem Biophys Res Commun; 1988 Apr; 152(2):857-61. PubMed ID: 3365255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
    Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J
    Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.